Announcements Trials
Browse Landscape

Phase

Phase 2 3Phase 3 1Phase 1/2 1

Status

Unknown 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1

Conditions

Sarcoma 22Precursor Cell Lymphoblastic Leukemia-Lymphoma 8Lymphoma 8Liposarcoma 8Hemangiosarcoma 8Fibrosarcoma 8Lymphoma, Large B-Cell, Diffuse 7Sarcoma, Synovial 6Rhabdomyosarcoma 6Neurofibrosarcoma 6Malignant mesenchymal tumor 6Leukemia 6Leiomyosarcoma 6Histiocytoma, Malignant Fibrous 6Hemangiopericytoma, Malignant 6Testicular Neoplasms 5Teratoma 5Neuroectodermal Tumors, Primitive, Peripheral 5Lung Neoplasms 5Carcinoma, Non-Small-Cell Lung 5Testicular Germ Cell Tumor 4Ovarian Neoplasms 4Lymphoma, Non-Hodgkin 4Endodermal Sinus Tumor 4Seminoma 3Neuroblastoma 3Neoplasm Metastasis 3Lymphoma, Follicular 3Hodgkin Disease 3Carcinoma, Embryonal 3

Interventions

Radiotherapy 1Proton Therapy 1Neoadjuvant Therapy 1Ifosfamide 1Heavy Ion Radiotherapy 1Fentanyl 1Doxorubicin 1Cyproheptadine 1Chemotherapy, Adjuvant 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 3 × Chondrosarcoma × Ifosfamide × Clear all
NCT00334854 2013-08-12

Ifosfamide and Doxorubicin, Radiation Therapy, and/or Surgery in Treating Young Patients With Localized Soft Tissue Sarcoma

National Cancer Institute (NCI)

Phase 3 Unknown
250 enrolled
Sarcoma

Hemangiopericytoma, Malignant, Chondrosarcoma, Fibrosarcoma, Hemangiosarcoma, Liposarcoma, Sarcoma, Dermatofibrosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡